Key Insights• Brazil's trauma fixation market is experiencing steady growth, driven by a high incidence of road accidents, sports injuries, and an aging population susceptible to osteoporosis related fractures. The market encompasses a wide range of internal and external fixation devices, including plates, screws, rods, and external fixators.• Brazil faces a substantial trauma burden. In 2025, orthopedic trauma admissions in the country are on track to exceed 900,000, with 60% of these related to fractures. The most common fractures include proximal femur, distal radius, tibia/fibula, and clavicle, affecting primarily two age groups which are 18–35 years and 60+ years.• The country has a vast healthcare infrastructure with approximately 7,191 hospitals, including specialized trauma centers such as the INTO in Rio de Janeiro, Santa Casa de São Paulo, Hospital do Trabalhador in Paraná, and Hospital Cristo Redentor in Rio Grande do Sul. The National Institute of Traumatology and Orthopedics is among Brazil's top-ranked hospitals.• The Brazilian medical device regulatory environment is governed by ANVISA (Agência Nacional de Vigilância Sanitária). Orthopedic fixation systems and associated devices are classified as Class III or IV (high to maximum risk) and require full registration with ANVISA, valid for ten years.

All orthopedic implants fall under Class III or IV risk categories.• The market is witnessing significant consolidation and investment activity. In March 2025, Swiss multinational Medartis acquired a 51% controlling stake in NeoOrtho, a Brazilian orthopedic solutions company, with the option to increase to 100% over four years. The acquisition also included a state-of-the-art modular plant scheduled to begin operations in late 2025.Market Outlook• According to the research report, "Brazil Trauma Devices Market Research Report, 2031," published by Actual Market Research, the Brazil Trauma Devices Market is anticipated to grow at more than 4.84% CAGR from 2026 to 2031.• The Brazil Trauma Fixation Market is witnessing steady growth, driven by increasing incidences of road accidents, sports injuries, and an aging population prone to osteoporosis-related fractures. The market encompasses implants, plates, screws, rods, and external fixation devices, with a significant shift toward minimally invasive and advanced fixation technologies.• Key trends include the adoption of biodegradable implants and minimally invasive surgical techniques, which reduce recovery times and improve patient outcomes. Local manufacturing initiatives and partnerships with international players are enhancing product accessibility and affordability. Government investments in healthcare infrastructure and rising private sector participation are expanding trauma care capabilities. Policies• The Brazilian Health Regulatory Agency (ANVISA) is the national regulatory authority responsible for medical devices in Brazil.

ANVISA categorizes medical devices into four types, medical equipment, materials for health use, orthopedic implants, and in vitro diagnostic medical devices. Medical devices are subject to ANVISA's health oversight, and before a product's manufacture, importation, or sale on the Brazilian market, a company must secure marketing authorization from ANVISA.• Brazil follows a risk-based classification system under ANVISA Resolution RDC 751/22. Class I (low risk) and Class II (medium risk) products are subject to prior filing with ANVISA, with authorization valid indefinitely. Class III (high risk) and Class IV (maximum risk) products are subject to registration with ANVISA, with authorization valid for ten years.• Orthopedic fixation systems and associated devices, including trauma implants, fall under Class III or IV and require full registration. All orthopedic implants are classified as Class III or IV risk categories. For Class III and IV devices, the registration process requires a full technical dossier, clinical evidence, and Good Manufacturing Practices (GMP) certification.Segment AnalysisBrazil Trauma Devices Market By Product Type• Internal fixation devices are used in approximately 900,000-1.3 million orthopedic trauma procedures annually in Brazil, including plates, screws, intramedullary nails, and locking fixation systems.

Major trauma hospitals typically maintain 35-70 fixation implant configurations to manage fracture cases across different regions. A standard fixation surgery requires approximately 5-15 implant components, while revision procedures associated with implant failure, infection, and delayed healing occur in around 60,000-100,000 cases annually.• External fixation devices support approximately 120,000-200,000 trauma procedures annually in Brazil, mainly for open fractures, road traffic injuries, severe limb trauma, and temporary stabilization. High volume trauma centers generally stock 20-40 external fixation frame systems for emergency applications. Each external fixation procedure typically requires 4-10 fixation pins or wires, with staged treatment commonly used for complex fractures.• Orthobiologics and synthetic bone grafts are utilized in approximately 150,000-250,000 trauma and reconstructive procedures annually in Brazil. These products are primarily used in fracture non-unions, bone defects, and revision surgeries, with average graft requirements ranging from 5-30 cc per procedure. Specialized orthopedic hospitals perform approximately 600-1,500 graft assisted trauma procedures annually for complex fracture reconstruction. Brazil Trauma Devices Market By Surgical Site / Anatomical Location• Upper extremity trauma devices are used in approximately 350,000-500,000 surgical procedures annually in Brazil, covering wrist, hand and forearm, clavicle, and humerus fractures.

Distal radius fractures account for approximately 120,000-180,000 treated cases annually due to falls, sports injuries, and workplace trauma. Hospital stays generally range from 2-5 days, followed by rehabilitation periods of 4-12 weeks.• Lower extremity trauma devices represent the largest application segment, supporting approximately 800,000-1.2 million procedures annually in Brazil. Femur, tibia, ankle, and hip fractures contribute significantly to trauma admissions, particularly from road accidents and occupational injuries. Complex lower-limb fixation procedures typically require 5-12 days of hospitalization, with rehabilitation extending 3-12 months.• Pelvic trauma devices are utilized in approximately 60,000-100,000 surgical interventions annually in Brazil. Pelvic and acetabular fractures contribute to around 150,000-250,000 trauma admissions annually, frequently associated with vehicle accidents and high energy injuries. Surgical pelvic fixation procedures generally require 10-18 days of hospitalization, followed by extended mobility rehabilitation. Brazil Trauma Devices Market By End User• Hospitals are the largest users of trauma devices in Brazil, supported by approximately 6,000-7,000 hospitals and healthcare facilities, including public trauma centers and private institutions.

These facilities manage the majority of emergency trauma cases and perform more than 1 million orthopedic trauma procedures annually. Major trauma hospitals typically handle 3,000-10,000 trauma surgeries annually and maintain extensive implant inventories.• Ambulatory Surgical Centers perform approximately 100,000-200,000 orthopedic trauma-related procedures annually in Brazil, mainly involving minor fracture fixation, implant removal, and outpatient interventions. Individual ASCs typically complete 1,000-4,000 orthopedic procedures annually. Urban ASCs increasingly support shorter stay trauma treatment pathways.• Orthopedic clinics manage approximately 15-25 million trauma-related consultations annually across Brazil, including fracture diagnosis, follow-up monitoring, rehabilitation planning, and implant surveillance. Individual orthopedic specialists commonly evaluate 40-90 trauma patients per week. Clinics provide essential long term recovery support through imaging, physiotherapy coordination, and post operative monitoring. Brazil Trauma Devices Market By Material Type• Stainless steel implants are used in approximately 350,000-600,000 trauma fixation procedures annually in Brazil, mainly for standard plates, screws, and routine fracture applications.

Regional hospitals continue to stock stainless steel systems due to affordability and proven mechanical strength. Implant retention commonly exceeds 5-10 years, with replacement procedures primarily linked to infection, discomfort, or mechanical issues.• Titanium and titanium alloy implants are utilized in approximately 800,000-1.2 million trauma procedures annually in Brazil, making them the preferred material for complex fracture fixation. These implants are widely used in long-bone fractures, pelvic reconstruction, and cranio-maxillofacial trauma. Implant retention frequently exceeds 10 years, reducing the need for secondary removal surgeries.• Bioabsorbable materials are used in approximately 30,000-70,000 trauma procedures annually in Brazil, mainly in pediatric fractures, sports injuries, and selected facial trauma applications. These materials gradually degrade over 12-36 months, minimizing additional removal procedures. Their adoption is concentrated in advanced orthopedic hospitals and private specialty centers.Considered in this report• Historic Year: 2020• Base year: 2025• Estimated year: 2026• Forecast year: 2031Aspects covered in this report• Trauma Devices Market with its value and forecast along with its segments• Various drivers and challenges• On-going trends and developments• Top profiled companies• Strategic recommendationBy Product Type• Internal Fixation Devices• External Fixation Devices• Orthobiologics & Synthetic Bone Grafts• Trauma Surgical Instruments & AccessoriesBy Surgical Site / Anatomical Location• Upper Extremity Trauma Devices• Lower Extremity Trauma Devices• Pelvic Trauma Devices• Cranio-Maxillofacial Trauma DevicesBy End User• Hospitals• Ambulatory Surgical Centers (ASCs)• Orthopedic ClinicsBy Material Type• Stainless Steel• Titanium & Titanium Alloys• Bioabsorbable Materials• Other Materials.